EBIT Margin (Annual)

EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues

Corcept Therapeutics Incorporated (CORT) had EBIT Margin of 5.88% for the most recently reported fiscal year, ending 2025-12-31.

Quarterly Annual

Figures for fiscal year ending 2025-12-31

Income Statement Financials
Revenue	$761.41M
Net Income	$98.17M
Cost of Goods Sold	$12.98M
Gross Profit	$748.43M
Operating Expenses	$716.61M
Operating Income	$44.80M
Non-Operating Income/Expense	$21.67M
Pre-Tax Income	$66.46M
Normalized Pre-Tax Income	$66.46M
Income after Taxes	$99.65M
Income from Continuous Operations	$99.65M
Consolidated Net Income/Loss	$99.65M
Normalized Income after Taxes	$99.65M
EBIT	$44.80M
EBITDA	$41.58M
Weighted-Average Shares Outstanding (Basic)	103.86M
Weighted-Average Shares Outstanding (Diluted)	119.99M
Earnings per Share (EPS) (Basic)	$0.95
Earnings per Share (EPS) (Diluted)	$0.82
Balance Sheet Financials
Current Assets	$485.46M
Property, Plant, and Equipment	$1.89M
Long-Term Assets	$351.19M
Total Assets	$836.65M
Current Liabilities	$166.09M
Long-Term Debt	$5.02M
Long-Term Liabilities	$22.76M
Total Liabilities	$188.85M
Common Equity	$647.80M
Tangible Shareholders Equity	$647.80M
Shareholders Equity	$647.80M
Common Shares Outstanding	105.97M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$142.00M
Cash Flow from Investing Activities	$69.76M
Cash Flow from Financial Activities	$-220.37M
Beginning Cash	$127.67M
End Cash	$120.50M
Increase/Decrease in Cash	$-7.17M
Stock-Based Compensation	$84.50M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	2.92
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.01
Debt to Equity Ratio	0.01
Gross Margin	98.30%
Operating Margin	5.88%
EBIT Margin	5.88%
EBITDA Margin	5.46%
Pre-Tax Profit Margin	8.73%
Profit Margin	12.89%
Free Cash Flow	$141.78M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.91
Inventory Turnover	1.01
Receiveable Turnover	12.74
Days Sales in Receivables	28.66
Return on Equity	15.38%
Return on Tangible Equity	15.38%
Return on Assets	11.91%
Return on Investments	15.26%
Book Value Per Share	$6.11
Free Cash Flow per Share	$1.18
Operating Cash Flow per Share	$1.18

Data from Zacks Investment Research, Inc.